Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel

Pubblicato online: 27 nov 2015

Pagine: 402 - 408

Ricevuto: 05 mag 2015

Accettato: 19 lug 2015

DOI: https://doi.org/10.1515/raon-2015-0038

Parole chiave

metastatic castration-resistant prostate cancer, comorbidity, chemotherapy

© 2015 Andrej Zist et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.